Home » CONNETICS LICENSES TECHNOLOGY FOR THE TREATMENT OF HYPERHIDROSIS
CONNETICS LICENSES TECHNOLOGY FOR THE TREATMENT OF HYPERHIDROSIS
Connetics Corporation, a specialty
pharmaceutical company that develops and commercializes dermatology products,
today announced it has obtained an exclusive, worldwide license to certain patented
technology that has potential utility in the treatment of hyperhidrosis. Connetics
has initiated a formulation development program utilizing this technology with
the goal of developing a safe, effective, well-tolerated and cosmetically elegant
topical formulation.
Business
Wire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May